Get started
Author

Arun Mistry

Fenfluramine hydrochloride for the treatment of seizures in Dravet syndrome: a randomised, double-blind, placebo-controlled trial
2019 · Lieven Lagae, Joseph Sullivan, et al. · The Lancet · 382
PDF
Fenfluramine for Treatment-Resistant Seizures in Patients With Dravet Syndrome Receiving Stiripentol-Inclusive Regimens
2019 · Rima Nabbout, Arun Mistry, et al. · JAMA Neurology · 251
PDF
Development and content validation of a preliminary core set of patient- and caregiver-relevant outcomes for inclusion in a potential composite endpoint for Dravet Syndrome
2017 · Rima Nabbout, Stephane Auvin, et al. · Epilepsy & Behavior · 80
Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg
2007 · Christopher R. Chapple, Aino Fianu-Jonsson, et al. · European Urology · 70
Setrusumab for the treatment of osteogenesis imperfecta: 12-month results from the phase 2b asteroid study
2024 · Francis H Glorieux, Bente Langdahl, et al. · Journal of Bone and Mineral Research · 40
The patient clinical journey and socioeconomic impact of osteogenesis imperfecta: a systematic scoping review
2023 · Maria Rapoport, Michael B. Bober, et al. · Orphanet Journal of Rare Diseases · 35
PDF
Safety and efficacy of leriglitazone in childhood cerebral adrenoleukodystrophy (NEXUS): an interim analysis of an open-label, phase 2/3 trial
2025 · Ángeles García-Cazorla, Caroline Sevin, et al. · EClinicalMedicine · 9
PDF
IP 1184. ZX008 (Fenfluramine) in Dravet’s Syndrome: First Results of a Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial
2018 · Tilman Polster, Lieven Lagae, et al. · Neuropediatrics · 3
Corrigendum to: “Treatment Outcomes in the STAR Study: A Subanalysis of Solifenacin 5 mg and Tolterodine ER 4 mg” [Eur Urol 2007;52:1195–1203]
2008 · Christopher R. Chapple, Aino Fianu-Jonsson, et al. · European Urology · 2
Fenfluramine HCl Provides Long-Term Clinically Meaningful Reduction in Seizure Frequency: Results of an Open-Label Extension Study
2019 · Sameer Zuberi, Helen J. Cross, et al. · Epilepsy & Behavior · 1
Effect of ZX008 (Fenfluramine HCl Oral Solution) on Total Seizures in Dravet Syndrome
2019 · Helen Cross, Sameer Zuberi, et al. · Epilepsy & Behavior
Long-Term Cardiovascular Safety of Fenfluramine HCl in the Treatment of Dravet Syndrome: Interim Analysis of an Open-Label Safety Extension Study
2019 · Lieven Lagae, Rima Nabbout, et al. · Epilepsy & Behavior
Less Convulsive Seizures by Fenfluramin Medication in Stiripentol Treated Patients with Dravet's Syndrome: Results from Randomized, Placebo-controlled Phase 3 Clinical Trial
2019 · Ulrich Stephani, Rima Nabbout, et al. · Neuropediatrics
Achieving Key Objectives In Rare Diseases Healthcare Policy In Spain: Contribution From A Dravet Syndrome Working Group
2017 · G Barker, A Mistry, et al. · Value in Health
Cultural relevance of the global impact of Dravet Syndrome in Australia, Italy, the US and UK
2017 · Rima Nabbout, Stephane Auvin, et al. · European Journal of Paediatric Neurology
Works count: 18
Citation count: 908
H-index: 8
I10-index: 7
Year
Topic
Type